LSBio: Acquires Absolute Antibody Ltd.

December 25, 2020

1004

Must read

Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

SEATTLE–(BUSINESS WIRE)–LSBio (LSBio™), pleased to announce its acquisition of Redcar, UK-based Absolute Antibody, Ltd. and its sister company Kerafast
Terms of the transaction were not disclosed
LSBio also provides IHC-validated reagent antibodies and services to the global community of academic, pharmaceutical, and biotech researchers
The Company has built a catalog of more than 750,000 reagent antibodies, assay kits, proteins, and biochemicals, and its acquisition of Absolute Antibody and Kerafast
The new acquisition combines a strong recombinant antibody portfolio with LSBio’s expertise in application-specific validation to make sequence-defined
The acquisition marks the latest investment by LSBio to rapidly build its product portfolio